COMMUNIQUÉS West-GlobeNewswire

PacBio Announces Appointment of Chris Smith to Board of Directors
30/01/2025
PacBio to leverage Chris' extensive expertise in diagnostics and laboratory testing markets, as Board Member David Meline steps down. MENLO PARK, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a [...]
Orion and Invenra announce discovery service and commercial license agreement to develop innovative bispecific antibody cancer therapeutics
30/01/2025
ORION CORPORATION PRESS RELEASE 30 JANUARY 2025 at 16.00 EET Orion and Invenra announce discovery service and commercial license agreement to develop innovative bispecific antibody cancer therapeutics Orion Corporation [...]
Niger becomes the first country in sub-Saharan Africa to eliminate the transmission of onchocerciasis
30/01/2025
DECATUR, Ga., Jan. 30, 2025 (GLOBE NEWSWIRE) -- On 30 January 2025, the World Health Organization (WHO) announced that Niger has been verified for eliminating the transmission of onchocerciasis, commonly known as river [...]
IRADIMED CORPORATION to Hold Fourth Quarter of 2024, Full Year of 2024 Financial Results Conference Call on February 13, 2025
30/01/2025
WINTER SPRINGS, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 fourth quarter financial results before the market opens on Thursday, [...]
Femasys Announces Notices of Intention to Grant for Two New European Patent Applications Covering Use of FemBloc Permanent Birth Control
30/01/2025
European patents expand coverage for both essential components of FemBloc for fallopian tube occlusion, resulting in non-surgical permanent contraception ATLANTA, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (Nasdaq [...]
Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences
30/01/2025
SAN FRANCISCO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, [...]
TOMI Environmental Reports Strong Start to 2025 with January Revenue Growth
30/01/2025
FREDERICK, Md., Jan. 30, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced positive [...]
Stereotaxis Announces First GenesisX Robotic System Order
30/01/2025
ST. LOUIS, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it has received the first order [...]
Mersana Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference
30/01/2025
CAMBRIDGE, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates ( [...]
Liberation Labs Closes $50.5 Million Convertible Note
30/01/2025
Brings total deployable capital raised to date to $125 million and will enable completion of first biomanufacturing plant in Richmond, Indiana RICHMOND, Ind., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Liberation Labs has closed [...]
Rentschler Biopharma announces strategic realignment of its global business operations
30/01/2025
LAUPHEIM, Germany, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today a realignment of its [...]
YuzuYello Named an Ad Age Best Place to Work 2025
28/01/2025
IPG Health agency honored with third recent noteworthy culture-focused award NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Yesterday, YuzuYello, an IPG Health company, announced that it has earned a top spot on Ad Age’s [...]
ANI Pharmaceuticals to Present at the Guggenheim Biotech Conference
28/01/2025
PRINCETON, N.J., Jan. 28, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, and Stephen Carey, Chief [...]
Zentalis Pharmaceuticals Announces Strategic Restructuring to Support Late-Stage Azenosertib Development
28/01/2025
Extended cash runway into late 2027, beyond a potentially registration-enabling azenosertib data readout from DENALI Part 2 Planned workforce reduction of approximately 40% of employees Corporate event to be held on [...]
Stryker announces definitive agreement for the sale of its U.S. spinal implants business and plans to sell related international business
28/01/2025
Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK), a global leader in medical technologies, announced today a definitive agreement to sell its U.S. spinal implants business to Viscogliosi Brothers [...]
Stryker announces the retirement of Glenn S. Boehnlein and the promotion of Preston Wells to Vice President, Chief Financial Officer
28/01/2025
Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that Glenn S. Boehnlein will retire from his role as Vice President, Chief Financial Officer. Boehnlein’s decision follows an [...]
Stryker reports 2024 operating results and 2025 outlook
28/01/2025
Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2024: Fourth Quarter Results Reported net sales increased 10.7% to $6.4 billion [...]
Eyenovia Announces 1-for-80 Reverse Stock Split
28/01/2025
Reverse stock split, when effective, is intended to restore compliance with the Nasdaq minimum bid price requirement while Eyenovia continues to evaluate a broad range of strategic alternatives NEW YORK, Jan. 28, 2025 ( [...]
Ascentage Pharma Announces Closing of U.S. Initial Public Offering
28/01/2025
ROCKVILLE, Md. and SUZHOU, China, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (Nasdaq: AAPG) (HKEX: 6855) announced today the closing of its U.S. initial public offering of 7,325,000 American depositary shares (“ [...]

Pages